Wednesday, July 16, 2025 7/16/2025

DEC-205+ Dendritic Cells are Effective at Stimulating a Protective T Cell Response Against WNV Encephalitis

Award Number: SC3GM130472
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 01/10/2019
PERIOD OF PERFORMANCE END DATE: 12/31/2023

Group Awards By:

View Award Description

DEC-205+ Dendritic Cells are Effective at Stimulating a Protective T Cell Response Against WNV Encephalitis - PROJECT SUMMARY West Nile virus (WNV) is a significant cause of neuronal injury and inflammation that results in severe disease that can potentially be lethal. In order to reduce or eliminate invading viruses from the central nervous system (CNS) and protect the brain, it is vital that T cells enter the virally-infected CNS and perform their anti-viral functions. However, due to the sensitivity of neurons, the presence activated T cells within the CNS may also contribute to neuropathology if not rigorously regulated. Previous research showed that dendritic cells (DCs) are critical for establishing virologic control within the CNS during WNV neuro-invasive disease. Yet, little is known as to how these cells accomplish protection without causing neuronal damage. We hypothesize that a specific subset of DCs (DEC-205-expressing DCs) promote virologic control and protection against WNV neuro-invasive disease through the appropriate activation of the T cells migrating into the virally-infected CNS. To address this hypothesis, we will use a well-established mouse model of WNV encephalitis, where one experimental group will be genetically deficient for the DEC-205 gene, effectively eliminating this subset of DCs from the brain and elsewhere. Using this model, we will be able to determine the role of these cells in limiting viral infection, replication, and neuronal injury within the WNV-infected CNS. We will also perform an adoptive transfer of these cells into the genetically deficient mice at a critical stage during WNV neuro-invasive disease. Through this study, we will determine the mechanisms by which this specific subset of DCs provide protection against WNV neuro- invasive disease. Together, these studies will illuminate and enhance our understanding of our immune responses to viral infections in the brain and the balance between an effective immune response and immunopathology with injury to neurons. It also has clear implications for the control and prevention of WNV neuro-invasive disease.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$12 )
2024	2022	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	000	4	6/6/2024	NON-COMPETING CONTINUATION	-$12
														Subtotal = -$12

Issue Date FY: 2022 ( Subtotal = $110,250 )
2022	2022	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	001	4	6/27/2022	NON-COMPETING CONTINUATION	$11,025
2022	2022	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	000	4	12/21/2021	NON-COMPETING CONTINUATION	$99,225
														Subtotal = $110,250

Issue Date FY: 2021 ( Subtotal = $110,250 )
2021	2021	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	001	3	2/17/2021	NON-COMPETING CONTINUATION	$11,025
2021	2021	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	000	3	1/11/2021	NON-COMPETING CONTINUATION	$99,225
														Subtotal = $110,250

Issue Date FY: 2020 ( Subtotal = $110,250 )
2020	2020	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	001	2	3/16/2020	NON-COMPETING CONTINUATION	$11,025
2020	2020	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	000	2	12/23/2019	NON-COMPETING CONTINUATION	$99,225
														Subtotal = $110,250

Issue Date FY: 2019 ( Subtotal = $110,250 )
2019	2019	CAL POLY POMONA FOUNDATION INC	3801 W TEMPLE AVE	POMONA	CA	91768	LOS ANGELES	USA	Biomedical Research and Research Training	000	1	1/10/2019	NEW	$110,250
														Subtotal = $110,250

Grand Total All Awards = $440,988

Top

All Categories

About

Search

Reports

Data Submission

Award Information

DEC-205+ Dendritic Cells are Effective at Stimulating a Protective T Cell Response Against WNV Encephalitis

Award Number: SC3GM130472

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 01/10/2019

PERIOD OF PERFORMANCE END DATE: 12/31/2023

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer